Loading…

Hepatocyte growth factor reverses the TGF-β-induced growth inhibition of CCL-64 cells: A novel bioassay for HGF and implications for the TGF-β bioassay

The influence of human hepatocyte growth factor (HGF) on the transforming growth factor β (TGF-β) bioassay CCL-64 was examined. HGF induced proliferation of the CCL-64 cells and potently counteracted TGF-β-induced growth inhibition. HGF was not inactivated by transient acidification to pH 2, a commo...

Full description

Saved in:
Bibliographic Details
Published in:Journal of immunological methods 1996-01, Vol.189 (1), p.59-64
Main Authors: Börset, Magne, Waage, Andres, Sundan, Andres
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The influence of human hepatocyte growth factor (HGF) on the transforming growth factor β (TGF-β) bioassay CCL-64 was examined. HGF induced proliferation of the CCL-64 cells and potently counteracted TGF-β-induced growth inhibition. HGF was not inactivated by transient acidification to pH 2, a commonly used procedure to activate latent TGF-β. HGF was a stronger mitogen for the mink lung cells than epidermal growth factor (EGF), a known stimulator of CCL-64 cell growth. Costimulation of the cells by these two cytokines resulted in an additive effect on proliferation. In complex biological fluids containing large amounts of HGF, the TGF-β concentration can be underestimated when determined by the CCL-64 assay. When a fixed amount of TGF-β is added, the CCL-64 cells can be used as a reliable bioassay for HGF with a sensitivity of about 1 ng/ml.
ISSN:0022-1759
1872-7905
DOI:10.1016/0022-1759(95)00228-6